Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis

被引：10

作者：

Mederacke, Ingmar ^{[2
]}

Witte, Torsten ^{[1
]}

Wedemeyer, Heiner ^{[2
]}

Meyer-Olson, Dirk ^{[1
]}

机构：

[1] Hannover Med Sch, Klin Immunol & Rheumatol, D-30625 Hannover, Germany

[2] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, D-30625 Hannover, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2011年 / 70卷 / 07期

关键词：

RHEUMATOID-ARTHRITIS; MANAGEMENT; THERAPY;

D O I：

10.1136/ard.2010.139824

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1343 / U192

页数：2

共 10 条

[1] Etanercept as prophylactic psoriatic therapy before interferon-α and ribavirin treatment for active hepatitis C infection [J].

Behnam, S. E. ;

Hindiyeh, R. ;

Fife, D. J. ;

Jeffes, E. W., III ;

Wu, J. J. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (04) :397-398

[2]

Cansu DÜ, 2008, J RHEUMATOL, V35, P421

[3] Diagnosis, Management, and Treatment of Hepatitis C: An Update [J].

Ghany, Marc G. ;

Strader, Doris B. ;

Thomas, David L. ;

Seeff, Leonard B. .

HEPATOLOGY, 2009, 49 (04) :1335-1374

[4] Chronic Hepatitis B: Update 2009 [J].

Lok, Anna S. F. ;

McMahon, Brian J. .

HEPATOLOGY, 2009, 50 (03) :661-662

[5] EASL Clinical Practice Guidelines: Management of chronic hepatitis B [J].

Marcellin, Patrick ;

Dusheiko, Geoffrey ;

Zoulim, Fabien ;

Esteban, Rafael ;

Hadziyannis, Stefanos ;

Lampertico, Pietro ;

Manns, Michael ;

Shouval, Daniel ;

Yurdaydin, Cihan .

JOURNAL OF HEPATOLOGY, 2009, 50 (02) :227-242

[6] Concomitant interferon-α therapy and tumor necrosis factor α inhibition for rheumatoid arthritis and hepatitis C [J].

Niewold, Timothy B. ;

Gibofsky, Allan .

ARTHRITIS AND RHEUMATISM, 2006, 54 (07) :2335-2337

[7] Treatment of HBV/HCV coinfection [J].

Potthoff, Andrej ;

Manns, Michael P. ;

Wedemeyer, Heiner .

EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (06) :919-928

[8] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs [J].

Smolen, Josef S. ;

Landewe, Robert ;

Breedveld, Ferdinand C. ;

Dougados, Maxime ;

Emery, Paul ;

Gaujoux-Viala, Cecile ;

Gorter, Simone ;

Knevel, Rachel ;

Nam, Jackie ;

Schoels, Monika ;

Aletaha, Daniel ;

Buch, Maya ;

Gossec, Laure ;

Huizinga, Tom ;

Bijlsma, Johannes W. J. W. ;

Burmester, Gerd ;

Combe, Bernard ;

Cutolo, Maurizio ;

Gabay, Cem ;

Gomez-Reino, Juan ;

Kouloumas, Marios ;

Kvien, Tore K. ;

Martin-Mola, Emilio ;

McInnes, Iain ;

Pavelka, Karel ;

van Riel, Piet ;

Scholte, Marieke ;

Scott, David L. ;

Sokka, Tuulikki ;

Valesini, Guido ;

van Vollenhoven, Ronald ;

Winthrop, Kevin L. ;

Wong, John ;

Zink, Angela ;

van der Heijde, Desiree .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) :964-975

[9] Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection [J].

Vassilopoulos, D. ;

Apostolopoulou, A. ;

Hadziyannis, E. ;

Papatheodoridis, G. V. ;

Manolakopoulos, S. ;

Koskinas, J. ;

Manesis, E. K. ;

Archimandritis, A. I. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) :1352-1355

[10] Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study [J].

Zein, NN .

JOURNAL OF HEPATOLOGY, 2005, 42 (03) :315-322

← 1 →